First Horizon Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

First Horizon Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.33K	Buy	+58	New	+$1.44K	﹤0.01%	2116
2024 Q3	–	Sell	-36	Closed	-$1.44K	–	2318
2024 Q2	$1.44K	Sell	36 -103	-74%	-$4.27K	﹤0.01%	2058
2024 Q1	$6.1K	Sell	139 -23	-14%	-$1.19K	﹤0.01%	1762
2023 Q4	$10K	Buy	162 +148	+1,057%	+$7.78K	﹤0.01%	1597
2023 Q3	$643	Buy	+14	New	+$764	﹤0.01%	2290
2022 Q3	–	Sell	-24	Closed	–	–	2261
2022 Q2	$0	Buy	+24	New	+$856	﹤0.01%	2355

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

First Horizon Advisors's AMPH Position: Q2 2025 in Review

First Horizon Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2025: 58 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #2116 among its holdings. This is a return to the name: First Horizon Advisors previously reported a position in AMPH as recently as Q2 2024.

First Horizon Advisors first reported a position in AMPH in Q2 2022 and has held it in 6 quarters since. The position peaked at $10K in Q4 2023. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

First Horizon Advisors held 58 shares of Amphastar Pharmaceuticals worth $1.33K as of Q2 2025.
Amphastar Pharmaceuticals was a new First Horizon Advisors position in Q2 2025.
Amphastar Pharmaceuticals made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2116 holding.
First Horizon Advisors first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
First Horizon Advisors's Amphastar Pharmaceuticals position peaked at $10K in Q4 2023.
245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.